Institutional members access full text with Ovid®

Share this article on:

The Challenges of Addressing Primary Prevention of Diabetes: A Response to Recommendations From the Chronic Disease Directors' Project

Namageyo-Funa, Apophia MPH; Nanavati, Parul MPH

Journal of Public Health Management and Practice: January-February 2008 - Volume 14 - Issue 1 - p 26–28
doi: 10.1097/01.PHH.0000303409.66485.47
Commentary

The growing burden of diabetes in the United States is leading public health entities to reconsider the focus of their efforts to prevent and control the disease. In particular, they are striving to include primary prevention in their agendas. Many program reports and projects, specifically the chronic disease directors project, recommend effective ways to prevent diabetes. Science supports the need for primary prevention of diabetes, but the most effective ways to implement the chronic disease directors project's recommendations remain unclear. The purpose of this commentary is to review the programmatic challenges faced by a federal diabetes public health entity, the Division of Diabetes Translation. These include limited funding, little coordination of primary prevention efforts among disease-oriented programs, limited research on effective interventions, and the large population at risk for developing diabetes. We discuss these challenges with reference to the primary prevention of diabetes, but they have broader implications for the different public health entities (federal, state, and nongovernmental organizations) with a vested interest in diabetes because they attempt to implement similar primary prevention recommendations for other diseases.

This commentary reviews the programmatic challenges faced by a federal diabetes public health entity, the Division of Diabetes Translation.

Apophia Namageyo-Funa, MPH, is Program Development Consultant, Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia.

Parul Nanavati, MPH, is Program Development Consultant, Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia.

Corresponding Author: Apophia Namageyo-Funa, MPH, Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop K-10, Atlanta, GA 30341 (aen5@cdc.gov).

© 2008 Lippincott Williams & Wilkins, Inc.